AREVA
Live / Applied — Statement of use — non-final action mailed (as of 13 Mar 2026)
What this means for you
Not registered yet, but its 25 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98466228
- Mark type
- Design + words
- Filed
- 25 Mar 2024
- Published for opposition
- 24 Dec 2024
- Attorney of record
- Michael S. Hargis
Goods and services
- Class 005 — Pharmaceuticals: House mark for pharmaceutical preparations for the treatment of cancer, heart failure, heart disease, and hypertension; house mark for pharmaceutical preparations for use in gene therapy; house mark for pharmaceutical preparations for the treatment of cancer, heart failure, heart disease, and hypertension, in the form of oncology injectables and oral solids
Owner
- Areva Pharmaceuticals Inc., Georgetown, IN, US
- Areva Pharmaceuticals Inc., Georgetown, IN, US
Prosecution history
- 09 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Jun 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 01 Jun 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 13 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Mar 2026 — NON-FINAL ACTION E-MAILED
- 13 Mar 2026 — SU - NON-FINAL ACTION - WRITTEN
- 03 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Apr 2025 — USE AMENDMENT FILED
- 05 May 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 05 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 May 2025 — POST PUBLICATION AMENDMENT – NOT ENTERED
- 28 Apr 2025 — ASSIGNED TO PETITION STAFF
- 22 Apr 2025 — TEAS STATEMENT OF USE RECEIVED